全球DNA与基因晶片市场

预计2030年全球DNA和基因晶片市场规模将达205亿美元

全球DNA和基因晶片市场规模预计在2024年为114亿美元，预计到2030年将达到205亿美元，2024年至2030年的复合年增长率为10.3%。报告分析的细分市场之一－耗材市场，预期复合年增长率为10.2%，到分析期结束时规模将达到126亿美元。测量设备市场在分析期间内的复合年增长率预计为10.5%。

美国市场预计将达到 29 亿美元，中国市场复合年增长率将达到 13.8%

预计到2024年，美国的DNA和基因晶片市场规模将达29亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到48亿美元，在2024-2030年的分析期间内，复合年增长率为13.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为6.7%和8.5%。在欧洲，预计德国市场的复合年增长率为7.8%。

全球 DNA 和基因晶片市场—主要趋势和驱动因素摘要

DNA 和基因晶片如何彻底改变基因研究和诊断？

DNA 晶片或基因晶片，也称为 DNA 微阵列，透过实现对基因表现和基因突变的高通量分析，正在彻底改变基因研究和诊断。这些晶片含有附着在固体表面的数千个 DNA 序列，使研究人员能够并行分析复杂的遗传讯息并快速识别基因表现模式。这种能力彻底改变了基因组学、药物基因组学和肿瘤学等领域，在这些领域，了解基因变异对于开发个人化医疗和标靶治疗至关重要。 DNA 晶片使医疗保健提供者能够识别与疾病相关的基因突变，从而对癌症、心臟病和遗传疾病等疾病进行更准确的诊断和个人化治疗。

除了临床应用外，DNA和基因晶片在药物研发中也发挥重要作用，使製药公司能够研究不同基因对药物化合物的反应。这加速了潜在治疗标靶的识别，从而缩短了开发时间和成本。在农业领域，基因晶片用于对植物进行基因分析，有助于提高作物产量和抗病能力。随着个人化医疗需求的增加和基因研究的进步，DNA和基因晶片已成为许多科学和临床领域必不可少的工具，能够更快、更准确地分析复杂的基因数据。

哪些技术进步正在塑造 DNA 和基因晶片市场？

生物资讯、微型化和高密度微阵列领域的创新引领着这一发展方向。生物资讯工具使研究人员能够分析基因晶片产生的大量遗传数据，从而深入了解基因表现模式并识别与特定疾病相关的突变。这些工具支持复杂的分析，包括全基因组关联研究 (GWAS)，从而扩展了我们对遗传因素对健康和疾病影响的理解。微型化和高密度阵列的进步也提高了基因晶片的容量，使得数百万个探针能够被放置在单一晶片上，从而最大限度地提高数据输出量并提高检测准确性。

此外，次世代定序仪(NGS) 的发展及其与基因晶片的整合扩大了可检测基因突变的范围，提高了诊断准确性并支持个人化治疗方案。晶片实验室技术的创新进一步提高了基因晶片的易用性，使其更易于临床应用。这些进步使医疗保健提供者能够在护理点进行快速基因检测，并及时提供重要疾病的诊断结果。随着技术的不断发展，DNA 和基因晶片正变得越来越强大、经济实惠且实用，使得高精度基因分析能够更大规模地实现。

为什么DNA和基因晶片对于个人化医疗至关重要？

DNA 和基因晶片对于个人化医疗至关重要，因为它们能够进行全面的基因分析，使医疗保健提供者能够为个别患者量身定制治疗方案。透过分析基因表现模式和检测基因突变，基因晶片可以深入了解患者对特定药物或疗法的反应。例如，基因晶片可以识别癌症相关基因的突变，使肿瘤学家能够根据患者独特的基因图谱选择最有效的标靶治疗。这种个人化方法可以改善治疗效果，降低药物不良反应的风险，进而提高病人安全性和照护品质。

除了癌症治疗外，基因晶片还用于评估多种疾病的遗传易感性，包括心血管疾病、糖尿病和精神疾病。利用这些信息，医疗保健提供者可以根据个人风险因素制定预防保健计划，使患者能够更有效地管理自身健康。基因晶片能够以低成本提供准确的基因讯息，从而扩大基因检测的可及性，使更多患者更接近实现个人化医疗。随着人们对个人化、数据主导医疗保健的日益关注，DNA和基因晶片正成为提供与个人基因图谱相对应的有针对性、有效治疗方案的重要工具。

推动 DNA 和基因晶片市场成长的因素是什么？

DNA和基因晶片市场的成长受到多种因素的推动，包括个人化医疗需求的不断增长、基因组学研究的进步以及基因检测技术投资的不断增加。随着医疗保健朝向个人化治疗方案迈进，DNA和基因晶片在实现精准基因分析、支援标靶治疗和促进预防医学方面发挥关键作用。生物资讯学和次世代定序(NGS) 的快速发展进一步推动了市场的发展，因为这些技术补充了基因晶片的功能，并能够更准确地检测基因突变。

基因组学研究资金的增加，以及医疗保健和製药业对基因检测的日益普及，也促进了市场的扩张。各国政府和私人机构正在投资基因组学计划，以更好地了解疾病的遗传因素，这推动了研究和临床领域对高通量DNA晶片的需求。此外，消费者对基因检测意识的不断增强，也导致了直接面向消费者的基因检测服务的增加，进一步推动了市场的成长。随着技术的进步以及DNA和基因晶片在医疗保健、农业和研究领域的应用不断扩展，预计市场将持续成长，并为各个领域提供创新和个人化的解决方案。

部分

产品（消耗品、设备）、应用（癌症诊断和治疗、基因表现、基因分型、药物发现、其他应用）、最终用途（学术和政府研究机构、医院和诊断中心、生物技术和製药公司、其他最终用途）

受访公司范例

• Affymetrix Inc
• Agilent Technologies Inc.
• Applied Microarrays Inc.
• Arrayit Corp.
• Biomerieux SA
• Biometrix Technology Inc.
• Bioneer Corp.
• Canon Inc.
• Capitalbio Corp.
• Cytopathfinder Inc.
• Eurofins Mwg Operon
• Exiqon
• Genisphere LLC
• Greiner Bio-One
• Hitachi Ltd.
• Illumina Inc.
• Integrated Dna Technologies
• LC Sciences
• Life Technologies Corp.
• Lifegen Technologies
• Macrogen Inc.
• Microarrays Inc.
• NGK Insulators Ltd.
• Ocimum Biosolutions Ltd.
• Oxford Gene Technology
• Pamgene International BV
• Perkinelmer
• Promega Corp.
• Roche Nimblegen Inc.
• Samsung Electronics Co Ltd.
• Savyon Diagnostics Ltd.
• Scienion AG
• Sequenom Inc.
• Shanghai Biochip Co Ltd.
• Sigma-Aldrich
• Surmodics Inc.
• Thermo Fisher Scientific Inc.
• Toshiba Corp.
• Wafergen Biosystems Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global DNA and Gene Chip Market to Reach US$20.5 Billion by 2030

The global market for DNA and Gene Chip estimated at US$11.4 Billion in the year 2024, is expected to reach US$20.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.6 Billion by the end of the analysis period. Growth in the Instrumentation segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 13.8% CAGR

The DNA and Gene Chip market in the U.S. is estimated at US$2.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

Global DNA and Gene Chip Market - Key Trends & Drivers Summarized

How Are DNA and Gene Chips Revolutionizing Genetic Research and Diagnostics?

DNA and gene chips, also known as DNA microarrays, are transforming genetic research and diagnostics by enabling high-throughput analysis of gene expression and genetic mutations. These chips contain thousands of DNA sequences attached to a solid surface, allowing researchers to analyze complex genetic information in parallel and quickly identify patterns in gene expression. This capability has revolutionized fields like genomics, pharmacogenomics, and oncology, where understanding genetic variations is essential for developing personalized medicine and targeted therapies. With DNA chips, healthcare providers can identify genetic mutations linked to diseases, guiding more accurate diagnoses and customized treatments for conditions like cancer, heart disease, and hereditary disorders.

In addition to clinical applications, DNA and gene chips play a crucial role in drug discovery, enabling pharmaceutical companies to test how different genes react to drug compounds. This accelerates the identification of potential therapeutic targets, reducing both development time and costs. In agriculture, gene chips are used to analyze plant genetics, helping improve crop yields and resistance to disease. As demand for personalized medicine grows and genetic research advances, DNA and gene chips have become indispensable tools across a range of scientific and clinical fields, supporting faster, more precise analysis of complex genetic data.

What Technological Advancements Are Shaping the DNA and Gene Chip Market?

Technological advancements are significantly enhancing the capabilities and applications of DNA and gene chips, with innovations in bioinformatics, miniaturization, and high-density microarrays leading the way. Bioinformatics tools allow researchers to analyze vast amounts of genetic data generated by gene chips, providing insights into genetic expression patterns and identifying mutations linked to specific diseases. These tools support complex analyses, including genome-wide association studies (GWAS), which have broadened our understanding of genetic influences on health and disease. Miniaturization and advances in high-density arrays have also increased the capacity of gene chips, enabling them to house millions of probes on a single chip, thereby maximizing data output and improving test accuracy.

In addition, the development of next-generation sequencing (NGS) and integration with gene chips has expanded the range of detectable genetic variants, enhancing diagnostic accuracy and supporting personalized treatment planning. Innovations in lab-on-a-chip technology have further improved gene chip usability, making them more accessible in clinical settings. These advancements allow healthcare providers to conduct rapid genetic testing at the point of care, providing timely results for critical conditions. As technology continues to evolve, DNA and gene chips are becoming more powerful, affordable, and practical, making high-precision genetic analysis available on a larger scale.

Why Are DNA and Gene Chips Essential in Personalized Medicine?

DNA and gene chips are essential to personalized medicine because they allow for comprehensive genetic profiling, enabling healthcare providers to tailor treatments to individual patients. By analyzing gene expression patterns and detecting genetic mutations, gene chips provide insights into how a patient may respond to specific medications or treatments, which is particularly valuable in fields like oncology. For example, gene chips can identify mutations in cancer-related genes, guiding oncologists to select the most effective targeted therapies for patients based on their unique genetic profiles. This personalized approach improves treatment outcomes and reduces the risk of adverse drug reactions, enhancing patient safety and quality of care.

In addition to cancer treatment, gene chips are used to assess genetic predispositions to various conditions, including cardiovascular disease, diabetes, and mental health disorders. With this information, healthcare providers can create preventive care plans tailored to individual risk factors, helping patients manage their health more effectively. The ability of gene chips to provide precise genetic information at a lower cost has expanded access to genetic testing, bringing personalized medicine closer to reality for more patients. As the focus on personalized, data-driven healthcare grows, DNA and gene chips are becoming essential tools for delivering targeted, effective treatments that cater to individual genetic profiles.

What Is Driving Growth in the DNA and Gene Chip Market?

The growth in the DNA and gene chip market is driven by several factors, including the rising demand for personalized medicine, advancements in genomics research, and increased investment in genetic testing technology. As healthcare moves toward individualized treatment approaches, DNA and gene chips play a crucial role in enabling precise genetic analysis, supporting targeted therapies, and facilitating preventive care. The rapid advancement of bioinformatics and next-generation sequencing (NGS) has further propelled the market, as these technologies complement gene chip capabilities, allowing for more accurate detection of genetic variants.

Increased funding for genomics research and growing adoption of genetic testing in healthcare and pharmaceutical sectors are also contributing to market expansion. Governments and private organizations are investing in genomics projects to enhance understanding of genetic factors in disease, which drives demand for high-throughput DNA chips in research and clinical settings. Moreover, the growing awareness of genetic testing among consumers is leading to an increase in direct-to-consumer genetic testing services, further fueling market growth. As technology improves and applications for DNA and gene chips expand across healthcare, agriculture, and research, the market is expected to experience sustained growth, supporting innovative, personalized solutions in various fields.

SCOPE OF STUDY:

The report analyzes the DNA and Gene Chip market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Instrumentation); Application (Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery, Other Applications); End-Use (Academic & Government Research Institutes, Hospitals & Diagnostic Centers, Biotech & Pharma Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Affymetrix Inc
• Agilent Technologies Inc.
• Applied Microarrays Inc.
• Arrayit Corp.
• Biomerieux SA
• Biometrix Technology Inc.
• Bioneer Corp.
• Canon Inc.
• Capitalbio Corp.
• Cytopathfinder Inc.
• Eurofins Mwg Operon
• Exiqon
• Genisphere LLC
• Greiner Bio-One
• Hitachi Ltd.
• Illumina Inc.
• Integrated Dna Technologies
• LC Sciences
• Life Technologies Corp.
• Lifegen Technologies
• Macrogen Inc.
• Microarrays Inc.
• NGK Insulators Ltd.
• Ocimum Biosolutions Ltd.
• Oxford Gene Technology
• Pamgene International B.V.
• Perkinelmer
• Promega Corp.
• Roche Nimblegen Inc.
• Samsung Electronics Co Ltd.
• Savyon Diagnostics Ltd.
• Scienion AG
• Sequenom Inc.
• Shanghai Biochip Co Ltd.
• Sigma-Aldrich
• Surmodics Inc.
• Thermo Fisher Scientific Inc.
• Toshiba Corp.
• Wafergen Biosystems Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Global Economic Update
  • DNA and Gene Chip - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Demand for Genomic Research Drives Growth of DNA and Gene Chip Market in Personalized Medicine
  • Rising Prevalence of Genetic Disorders and Cancers Spurs Adoption of DNA and Gene Chips for Early Diagnosis
  • Advancements in Microarray Technology Improve Accuracy and Efficiency in DNA and Gene Chip Applications
  • Growing Focus on Personalized Medicine and Pharmacogenomics Enhances Demand for DNA and Gene Chips in Drug Development
  • Expansion of Precision Medicine Initiatives Globally Fuels Market for DNA and Gene Chips in Targeted Therapies
  • Increasing Application of DNA and Gene Chips in Oncology Research Expands Market for Cancer Diagnostics
  • Growth in Agricultural Biotechnology for Crop Improvement Drives Demand for DNA and Gene Chips in Agrigenomics
  • Emergence of Direct-to-Consumer Genetic Testing Increases Adoption of DNA and Gene Chips in Consumer Genomics
  • Rising Application of DNA and Gene Chips in Infectious Disease Research Expands Use in Pathogen Detection
  • Increased Focus on Biomarker Discovery in Research and Diagnostics Fuels Development of DNA and Gene Chip Solutions
  • Technological Advancements in Genomics and Bioinformatics Enhance Application and Accuracy of DNA and Gene Chips
  • Growing Role of DNA and Gene Chips in Neurogenetics for Early Diagnosis and Research in Neurological Disorders
  • Expansion of Next-Generation Sequencing (NGS) Capabilities Increases Use of DNA Chips in Genomic Analysis
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for DNA and Gene Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Biotech & Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Government Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Academic & Government Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Academic & Government Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Cancer Diagnosis & Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Cancer Diagnosis & Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Cancer Diagnosis & Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Gene Expression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Gene Expression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Gene Expression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 30: World 15-Year Perspective for Genotyping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 31: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 32: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 33: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 34: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 35: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 36: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 37: World DNA and Gene Chip Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for DNA and Gene Chip by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for DNA and Gene Chip by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for DNA and Gene Chip by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for DNA and Gene Chip by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION